(-0.03%) 5 212.00 points
(-0.05%) 39 007 points
(-0.05%) 18 190 points
(-0.54%) $77.96
(0.32%) $2.21
(0.15%) $2 327.60
(0.31%) $27.63
(-0.03%) $988.10
(0.17%) $0.931
(0.42%) $10.95
(0.18%) $0.801
(-0.02%) $91.43
Quarter results tomorrow
(bmo 2024-05-09)
Expected move: +/- 10.78%
-6.05% $ 0.827
@ $0.697
Wydano: 14 vas. 2024 @ 16:37
Zwrot: 18.62%
Poprzedni sygnał: vas. 12 - 21:32
Poprzedni sygnał:
Zwrot: 4.84 %
Live Chart Being Loaded With Signals
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform...
Stats | |
---|---|
Dzisiejszy wolumen | 832 209 |
Średni wolumen | 796 263 |
Kapitalizacja rynkowa | 79.85M |
EPS | $0 ( 2024-03-20 ) |
Następna data zysków | ( $-0.120 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.960 |
ATR14 | $0.00600 (0.71%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-15 | Orlinger Klaus | Buy | 367 300 | Stock Option (Right to Buy) |
2024-04-15 | Aldag Jorn | Buy | 971 400 | Stock Option (Right to Buy) |
2024-04-15 | Winderlich Mark | Buy | 250 000 | Stock Option (Right to Buy) |
2024-04-15 | Winderlich Mark | Buy | 50 000 | Stock Option (Right to Buy) |
2024-04-15 | Kandera Reinhard | Buy | 406 200 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
98.82 |
Last 94 transactions |
Buy: 7 455 375 | Sell: 565 370 |
Wolumen Korelacja
HOOKIPA Pharma Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
TCRT | 0.916 |
VSTA | 0.914 |
JNCE | 0.904 |
INFI | 0.903 |
MPAA | 0.903 |
VCSA | 0.902 |
POWW | 0.899 |
VIRX | 0.899 |
GRAY | 0.897 |
TOI | 0.896 |
10 Najbardziej negatywne korelacje | |
---|---|
IMMR | -0.897 |
PBFS | -0.892 |
BNIXU | -0.887 |
ISIG | -0.875 |
WEN | -0.873 |
CCRC | -0.872 |
MGI | -0.869 |
SEDG | -0.864 |
IBEX | -0.862 |
MSON | -0.859 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
HOOKIPA Pharma Inc Korelacja - Waluta/Towar
HOOKIPA Pharma Inc Finanse
Annual | 2023 |
Przychody: | $20.13M |
Zysk brutto: | $16.58M (82.35 %) |
EPS: | $-0.860 |
FY | 2023 |
Przychody: | $20.13M |
Zysk brutto: | $16.58M (82.35 %) |
EPS: | $-0.860 |
FY | 2022 |
Przychody: | $14.25M |
Zysk brutto: | $10.65M (74.72 %) |
EPS: | $-0.990 |
FY | 2021 |
Przychody: | $18.45M |
Zysk brutto: | $18.45M (100.00 %) |
EPS: | $-2.79 |
Financial Reports:
No articles found.
HOOKIPA Pharma Inc
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers. The company's preclinical stage products include HB-300 program for prostate cancer; and HB-700 for targeting mutated KRAS in pancreatic, colorectal, and lung cancer. HOOKIPA Pharma Inc. has a collaboration with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products using or incorporating its replicating and non-replicating technology platforms for the treatment, cure, diagnosis, or prevention of Hepatitis B Virus. The company was incorporated in 2011 and is headquartered in New York, New York.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej